• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哌醋甲酯反应和副作用特征的高度家族相关性。

High Familial Correlation in Methylphenidate Response and Side Effect Profile.

机构信息

1 Tel Aviv University, Israel.

2 The Edmond and Lily Safra Children's Hospital, Tel Hashomer, Israel.

出版信息

J Atten Disord. 2019 Jan;23(2):135-139. doi: 10.1177/1087054715580844. Epub 2015 Apr 21.

DOI:10.1177/1087054715580844
PMID:25899797
Abstract

OBJECTIVE

To examine whether a familial tendency exists in clinical response to methylphenidate.

METHOD

Nineteen pairs of siblings or parent-child stimulant-naive individuals with ADHD were prescribed methylphenidate-immediate release, and were comprehensively evaluated at baseline, Week 2, and Week 4, using the ADHD Rating Scale IV, Clinical Global Impression Scale, and the Barkley Side Effects Rating Scale.

RESULTS

We found significant intraclass correlations in family member response to methylphenidate-immediate release and side effect profile, including emotional symptoms and loss of appetite and weight.

CONCLUSION

Family history of response to methylphenidate should be taken into account when treating ADHD.

摘要

目的

研究哌醋甲酯治疗的临床反应是否存在家族倾向。

方法

19 对 ADHD 未用药的兄弟姐妹或亲子被处方哌醋甲酯速释剂,并在基线、第 2 周和第 4 周使用 ADHD 评定量表-IV、临床总体印象量表和 Barkley 副作用评定量表进行全面评估。

结果

我们发现哌醋甲酯速释剂治疗反应和副作用特征(包括情绪症状、食欲不振和体重减轻)在家庭成员之间存在显著的组内相关性。

结论

在治疗 ADHD 时,应考虑家族对哌醋甲酯的反应史。

相似文献

1
High Familial Correlation in Methylphenidate Response and Side Effect Profile.哌醋甲酯反应和副作用特征的高度家族相关性。
J Atten Disord. 2019 Jan;23(2):135-139. doi: 10.1177/1087054715580844. Epub 2015 Apr 21.
2
Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.缓释和长效释放型哌甲酯(HLD200)治疗注意缺陷/多动障碍儿童的疗效与安全性
J Child Adolesc Psychopharmacol. 2017 Aug;27(6):474-482. doi: 10.1089/cap.2017.0084. Epub 2017 Jul 21.
3
A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.盐酸哌甲酯控释片治疗注意缺陷多动障碍儿童的剂量反应研究。
Pediatrics. 2003 Nov;112(5):e404. doi: 10.1542/peds.112.5.e404.
4
Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.哌甲酯和右旋苯丙胺治疗儿童注意力缺陷多动障碍的副作用:一项双盲交叉试验
Pediatrics. 1997 Oct;100(4):662-6. doi: 10.1542/peds.100.4.662.
5
Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial.多动症儿童使用哌甲酯期间的周末假期:一项随机临床试验。
J Child Adolesc Psychopharmacol. 2004 Summer;14(2):195-206. doi: 10.1089/1044546041649066.
6
Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.丁螺环酮与哌甲酯治疗儿童注意力缺陷/多动障碍的随机双盲研究
Acta Med Iran. 2012;50(11):723-8.
7
Efficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHD.新型哌醋甲酯缓释口服混悬剂(MEROS)治疗 ADHD 的疗效、安全性和耐受性。
J Atten Disord. 2017 Dec;21(14):1180-1191. doi: 10.1177/1087054714533191. Epub 2014 May 29.
8
Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD.家长和教师观察到 ADHD 儿童的哌醋甲酯治疗反应与不良反应之间的关系。
BMC Psychiatry. 2011 Apr 21;11:70. doi: 10.1186/1471-244X-11-70.
9
Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.银杏叶提取物治疗儿童和青少年注意缺陷多动障碍:一项双盲、随机对照试验。
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):76-80. doi: 10.1016/j.pnpbp.2009.09.026. Epub 2009 Oct 5.
10
Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.肾上腺素能α2A受体基因与哌甲酯改善注意缺陷多动障碍儿童及青少年注意力不集中症状的相关性
Arch Gen Psychiatry. 2007 Feb;64(2):218-24. doi: 10.1001/archpsyc.64.2.218.

引用本文的文献

1
Exploring the impact of stimulant medications on weight in children with attention deficit hyperactivity disorder in Dubai, United Arab Emirates.探索刺激性药物对阿拉伯联合酋长国迪拜患有注意力缺陷多动障碍儿童体重的影响。
Front Psychiatry. 2024 Oct 16;15:1392846. doi: 10.3389/fpsyt.2024.1392846. eCollection 2024.
2
Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan.哌醋甲酯剂量与 ADHD 患者的创伤性脑损伤:台湾基于人群的研究。
Eur Child Adolesc Psychiatry. 2018 Mar;27(3):279-288. doi: 10.1007/s00787-017-1042-7. Epub 2017 Aug 30.
3
The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan.
哌甲酯治疗与年轻多动症患者骨折风险之间的关联:一项基于台湾全国人口的研究。
PLoS One. 2017 Mar 15;12(3):e0173762. doi: 10.1371/journal.pone.0173762. eCollection 2017.